UVA Health researchers have developed a powerful new risk assessment tool for predicting outcomes in heart failure patients. The researchers have made the tool publicly available for free to clinicians.
Experts Warn on Mixing New Alzheimer’s Drug and Antidepressants
Mixing lecanemab (Leqembi) and certain antidepressants may signal caution, Swiss researchers said. Some patients have a higher risk of intracerebral hemorrhage in the first 30